Skip to main content
Clinical Trials/NCT01833429
NCT01833429CompletedNot Applicable

Circadian Autonomic Disturbances in Resistant Hypertension With and Without White-coat Phenomenon

University of Campinas, Brazil1 site in 1 country44 target enrollmentStarted: September 2011Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
44
Locations
1
Primary Endpoint
evaluation of the autonomic function in resistant hypertensive patients

Study Overview

Brief Summary

The contribution of this study is the unedited evaluation of the circadian autonomic profiles of resistant hypertension with and without white-coat response.

Detailed Description

All patients were submitted to office blood pressure measurement, Ambulatory blood pressure monitoring and 24-hour Holter monitoring.

Baseline blood samples for the measurement of glycemia (mg/dL), total cholesterol (mg/dL), LDL cholesterol (mg/dL), triglycerides (mg/dL), creatinine (mg/dL), serum uric acid, serum sodium, serum potassium, plasma aldosterone concentration (PAC) and plasma renin activity (PRA) were collected at 08:00 after overnight fasting.

Study Design

Study Type
Observational
Observational Model
Cohort

Eligibility Criteria

Ages
30 Years to 60 Years (Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • resistant hypertensive patients

Exclusion Criteria

  • White-coat hypertension
  • obstructive sleep apnea

Outcomes

Primary Outcomes

evaluation of the autonomic function in resistant hypertensive patients

Time Frame: 10 months

The autonomic nervous system can be assessed by the heart rate variability. Variations in heart rate variability are normally observed in association with diurnal rhythms and blood pressure changes. The heart rate variability parameters are different in many studies, although the consensus is that lower values of the indices of vagal as well as high indices of sympathetic functions are associated prospectively with death and disability. In humans, the disturbances of the circadian rhythms of heart rate variability and blood pressure have been intensively studied, mainly due to the increased cardiovascular death reported during the morning hours

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
University of Campinas, Brazil
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Valéria Nasser Figueiredo

PhD

University of Campinas, Brazil

Study Sites (1)

Loading locations...

Similar Trials